Literature DB >> 13742165

The mode of action of alkylating agents. II. Studies of the metabolism of myleran. The reaction of myleran with some naturally occurring thiols in vitro.

J J ROBERTS, G P WARWICK.   

Abstract

Entities:  

Keywords:  BUSULFAN/metabolism; SULFHYDRYL COMPOUNDS/metabolism

Mesh：

Substances：

Year:  1961        PMID： 13742165     DOI： 10.1016/0006-2952(61)90132-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

1.  IN VIVO EFFECTS OF METHYLENE DIMETHANESULPHONATE ON PROLIFERATING CELL SYSTEMS.

Authors:  B W FOX; H JACKSON
Journal:  Br J Pharmacol Chemother       Date:  1965-02

2.  Cross-linking between histones and DNA following treatment with a series of dimethane sulphonate esters.

Authors:  J A Hartley; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Metabolism of 14C-busulfan in isolated perfused rat liver.

Authors:  M Hassan; H Ehrsson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jan-Mar       Impact factor: 2.441

4.  Busulfan therapy of central nervous system xenografts in athymic mice.

Authors:  R H Aaron; G B Elion; O M Colvin; M Graham; S Keir; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Authors:  Alan L Myers; Jitesh D Kawedia; Richard E Champlin; Mark A Kramer; Yago Nieto; Romi Ghose; Borje S Andersson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2017-08-17       Impact factor: 4.481

6.  SOME BIOCHEMICAL ASPECTS OF LEUKAEMIAS: THE APPEARANCE OF A SOLUBLE DISULPHIDE IN THE BLOOD IN CHRONIC GRANULOCYTIC LEUKAEMIA.

Authors:  K R HARRAP; D E SPEED
Journal:  Br J Cancer       Date:  1964-12       Impact factor: 7.640

7.  Impact of GSTA1 Polymorphisms on Busulfan Oral Clearance in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Veronique Michaud; My Tran; Benoit Pronovost; Philippe Bouchard; Sarah Bilodeau; Karine Alain; Barbara Vadnais; Martin Franco; François Bélanger; Jacques Turgeon
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.